Pharma

Pharma

Pfizer and GSK to battle for share of new RSV vaccine market, says GlobalData

The European Commission (EC) recently approved GSK’s novel vaccine, Arexvy, for the prevention of lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older, making it the first RSV vaccine available across the EU. Arexvy was also approved by the FDA in May, becoming the first […]

Pharma

Cannabinoids hold potential to be future of pain medication and address opioid epidemic, says GlobalData

On May 9, National Fentanyl Awareness Day was observed in recognition of the US opioid crisis. Accordingly, the development of non-opioid painkillers is experiencing a surge in activity, and despite numerous novel targets receiving high levels of attention, cannabinoids have emerged as strong favorites to replace opioid-related medications. As a result, they hold the potential […]

Pharma

Merck lawsuit against US government raises constitutional concerns over drug pricing regulation, says GlobalData

Pharmaceutical giant Merck has filed a lawsuit in the US District Courts against the federal government, claiming it violates constitutional rights and undermines drug pricing negotiation powers. The lawsuit could have significant implications for the future of drug pricing regulation and may prompt other pharmaceutical companies to challenge the Inflation Reduction Act as well, says […]

Pharma

International NASH Day response reveals growing interest in raising disease awareness, says GlobalData

The increased response to International NASH Day (8 June) in 2023 demonstrates growing interest from both industry and public bodies in raising the awareness of non-alcoholic steatohepatitis (NASH). This reflects the rising prevalence of the disease, as well as recent clinical trial developments, says GlobalData, a leading data and analytics company. Jay Patel, Pharma Analyst […]

Pharma

Mixed prospects for Merck lawsuit against US federal government, says GlobalData

Pharmaceutical giant Merck has filed a lawsuit in the US District Courts against the federal government alleging that the drug pricing clauses of the Inflation Reduction Act of 2022 violates the First and Fifth Amendments to the US Constitution. Although prior judgements raise questions about the First Amendment claim, there are some indications that the […]

Pharma

Global Alzheimer’s disease market to reach $13.7bn in 2030 driven by novel drug launches, forecasts GlobalData

The Alzheimer’s disease (AD) market is projected to experience robust growth at a compound annual growth rate of 20.0% from $2.2 billion in 2020 to $13.7 billion in 2030 across the eight major markets (8MM*). This expansion is primarily attributed to the introduction of pioneering therapies aimed at addressing the challenges posed by AD, says […]

Pharma

New approvals set to revolutionize myelofibrosis treatment landscape across 8MM, says GlobalData

The treatment paradigm for myelofibrosis (MF) – a rare type of blood cancer – is expected to experience marked transformation over the next decade in the world’s eight major markets (8MM*) due to numerous late-stage pipeline therapies potentially becoming the new standards of care, according to GlobalData, a leading data and analytics company. GlobalData’s latest […]

Pharma

Strong safety data to support etrasimod entry to ulcerative colitis market, says GlobalData

The market for ulcerative colitis (UC) is filled with a number of different treatment options, and the pipeline is relatively strong. Pfizer’s etrasimod is a notable agent in the late-stage UC pipeline which is a once-daily oral sphingosine-1-phosphate (S1P) modulator. The company recently presented long-term safety data spanning 2.5 years at the Digestive Disease Week […]

Pharma

AbbVie’s Rinvoq for Crohn’s Disease to see rapid uptake by healthcare providers, says GlobalData

The FDA recently announced the approval of Rinvoq (upadacitinib), AbbVie’s Janus kinase inhibitor (JAKi), to treat adults with moderately to severely active Crohn’s Disease (CD) who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers. The decision was based on data from two randomized induction trials, U-EXCEED (NCT03345836) […]

Pharma

Alnylam patent lawsuit against Pfizer, Moderna highlights escalating legal pressure on big pharma companies, says GlobalData

Biotech company Alnylam Pharmaceuticals has filed a third patent lawsuit against Pfizer and Moderna, alleging unauthorized use of its proprietary lipid nanoparticle (LNP) vaccine delivery technology in their COVID-19 vaccines. This move highlights the escalating legal pressure on big pharma companies as they face multiple claims related to LNP technology, with Alnylam seeking substantial royalty […]

Pharma

Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson (J&J), has recently released new data on Tremfya (guselkumab), a monoclonal antibody that targets IL-23 in adults with moderate-to-severe plaque psoriasis (PsO). Tremfya, the first approved IL-23 inhibitor in the US, has potential for various indications and is forecasted to generate $8.6 billion in global sales by […]

Pharma

Novo Nordisk’s limit on Wegovy supply vital to retain its competitive advantage, says GlobalData

Novo Nordisk recently announced that the starter doses of Wegovy (semaglutide) would be limited in the US until September, in an effort to avoid supply shortages. The move comes after the company faced a supply shortage issue in March 2022, which resulted in halted sales of Wegovy and a delay in launching in the EU. […]

Pharma

China poised to lead the way with world’s first oral insulin for type 2 diabetes, says GlobalData

Hefei Tianhui Biotechnology Co. Ltd. (HTIT) has recently submitted a marketing authorization application (MAA) in China for the world’s first oral insulin for type 2 diabetes (T2D). If approved, China will become the world’s first country with oral insulin availability, says GlobalData, a leading data and analytics company. According to GlobalData’s Pharma Intelligence Center, there are […]

Pharma

Parkinson’s unmet needs present significant opportunity for new entrants, says GlobalData

Parkinson’s Disease (PD) is a complex, multi-system neurodegenerative disorder that affects movement control. Current treatments focus on the management of dopamine levels in the brain, with levodopa-based therapies remaining the standard of care in the PD market for the past half century. However, the effectiveness of levodopa declines with time, and both motor and non-motor […]

Pharma

New study findings hold potential for new treatment option to prevent stroke in AF patients, says GlobalData

At the 2023 annual congress of the European Heart Rhythm Association (EHRA 2023), new real-world data was presented by researchers from Hong Kong, demonstrating that the risk of strokes was lower in atrial fibrillation (AF) patients who had been using statins within a year of their diagnosis. While the benefit of statins in AF patients […]

Pharma

Tibsovo’s EU approval game changer for patients with acute myeloid leukemia and bile duct cancer in Europe, says Globaldata

Servier Pharmaceuticals recently announced the European Commission (EC) approval of Tibsovo (ivosidenib), as a targeted therapy in two difficult-to-treat oncology indications, acute myeloid leukemia (AML) and advanced cholangiocarcinoma. This marks the first IDH1 inhibitor approved in Europe and will be a game changer for patients with AML and cholangiocarcinoma in Europe, as Tibsovo addresses the […]

Pharma

Immatics’ IMA203 clinical data to boost TCR-T therapy development in solid tumour, says GlobalData

Immunotherapy-focused biotech Immatics recently announced encouraging interim clinical data from one of the three cohorts of its Phase Ib trial evaluating its leading T-cell receptor-based T-cell (TCR-T) therapy candidate, IMA203. The positive data represents considerable progress in the development of adoptive cell therapies (ACTs) for the treatment of solid cancers, says GlobalData, a leading data […]

Pharma

Ultomiris, Hemlibra, Vafseo instrumental in driving hematological disorders market, reveals GlobalData

The hematological disorders market is undergoing an impressive surge in sales, cementing its position as the fastest-growing therapy area for the second consecutive year. Notably, this growth is not evenly distributed, with 45% of the sales growth being driven by just three drugs: Alexion Pharmaceuticals’s Ultomiris (ravulizumab-cwvz), Genentech’s Hemlibra (emicizumab-kxwh), and Akebia Therapeutics’s Vafseo (vadadustat), […]

Pharma

Phase I completion of Sanofi vWD therapy demonstrates significant potential of pipeline, says GlobalData

Sanofi has successfully completed the Phase I trial for its von Willebrand disease (vWD) therapy, efanesoctocog alfa (BIV001), a novel antihemophilic factor recombinant fusion protein that acts as a coagulation factor VIII therapy. This is a significant potential addition to the future of the late stage vWD pipeline, which currently lacks novel molecules and therapies […]

Pharma

Competition for therapies targeting folate receptor alpha expected to intensify, says GlobalData

Global market for FRα-targeted therapy in cancer is expected to increase from $3 million in 2022 to $921 million in 2029, with a CAGR of 126.7% ImmunoGen’s Elahere is at the forefront of the race in terms of development and is the only FRα therapy approved in the oncology field The increasing competition in this […]

Prev 1 … 33 34 35 36 37 … 108 Next

Pfizer and GSK to battle for share of new RSV vaccine market, says GlobalData

Cannabinoids hold potential to be future of pain medication and address opioid epidemic, says GlobalData

Merck lawsuit against US government raises constitutional concerns over drug pricing regulation, says GlobalData

International NASH Day response reveals growing interest in raising disease awareness, says GlobalData

Mixed prospects for Merck lawsuit against US federal government, says GlobalData

Global Alzheimer’s disease market to reach $13.7bn in 2030 driven by novel drug launches, forecasts GlobalData

New approvals set to revolutionize myelofibrosis treatment landscape across 8MM, says GlobalData

Strong safety data to support etrasimod entry to ulcerative colitis market, says GlobalData

AbbVie’s Rinvoq for Crohn’s Disease to see rapid uptake by healthcare providers, says GlobalData

Alnylam patent lawsuit against Pfizer, Moderna highlights escalating legal pressure on big pharma companies, says GlobalData

Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData

Novo Nordisk’s limit on Wegovy supply vital to retain its competitive advantage, says GlobalData

China poised to lead the way with world’s first oral insulin for type 2 diabetes, says GlobalData

Parkinson’s unmet needs present significant opportunity for new entrants, says GlobalData

New study findings hold potential for new treatment option to prevent stroke in AF patients, says GlobalData

Tibsovo’s EU approval game changer for patients with acute myeloid leukemia and bile duct cancer in Europe, says Globaldata

Immatics’ IMA203 clinical data to boost TCR-T therapy development in solid tumour, says GlobalData

Ultomiris, Hemlibra, Vafseo instrumental in driving hematological disorders market, reveals GlobalData

Phase I completion of Sanofi vWD therapy demonstrates significant potential of pipeline, says GlobalData

Competition for therapies targeting folate receptor alpha expected to intensify, says GlobalData

Browse

Company information